0001209191-18-007593.txt : 20180205
0001209191-18-007593.hdr.sgml : 20180205
20180205172224
ACCESSION NUMBER: 0001209191-18-007593
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180201
FILED AS OF DATE: 20180205
DATE AS OF CHANGE: 20180205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Po Shun
CENTRAL INDEX KEY: 0001661335
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 18575254
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-225-0096
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-01
0
0001445283
PROTEOSTASIS THERAPEUTICS, INC.
PTI
0001661335
Lee Po Shun
C/O PROTEOSTASIS THERAPEUTICS, INC.
200 TECHNOLOGY SQUARE, 4TH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
See Remarks
Restricted Stock Units
2018-02-01
4
A
0
26046
0.00
A
Common Stock
26046
26046
D
Each restricted stock unit represents a contingent right to receive one share of PTI common stock.
The restricted stock units shall vest in full on February 1, 2019.
Executive Vice President and Chief Medical Officer
/s/ Janet Smart, Attorney-in-Fact
2018-02-05